Navigation Links
Rotigotine Transdermal System Shows Significant Symptom Reduction and Tolerability in Patients with Restless Legs Syndrome
Date:10/8/2007

severity of their RLS at four periods during the night and day, as well as sleep satisfaction and daytime tiredness.

A synopsis of rotigotine RLS clinical data presented at the meeting follows.

Six-Month Studies in Patients with Moderate-to-Severe Idiopathic RLS

SP 790

* In a multi-center, double-blind, placebo-controlled, Phase III trial,

458 patients were studied in eight European countries

* Rotigotine was studied in doses of 1, 2 and 3 mg/24 hours over a period

of six months

* The study showed a statistically significant improvement in the IRLS sum

score and a clinically relevant reduction in the CGI Item-1 (severity of

illness) score compared to placebo

* The mean baseline scores were: IRLS 28.1 plus or minus 6.1 and CGI 5.0

plus or minus 0.8 reflecting moderate-to-severe symptoms at baseline

* The net effects over placebo after 6 months of treatment were -5.1 plus

or minus 1.3, -7.5 plus or minus 1.3, and -8.2 plus or minus 1.3 in the

IRLS and -0.76 plus or minus 0.19, -1.07 plus or minus 0.19 and -1.21

plus or minus 0.19 in CGI Item-1 for rotigotine 1, 2, and 3 mg/24 hours

respectively (p < 0.001 for all comparisons)

* Rotigotine was also shown to be generally well-tolerated

* The most common adverse events that were determined by the investigators

to be drug-related were application site reactions, nausea, headache and

dizziness

SP 792

* In a multi-center, double-blind, placebo-controlled, Phase III trial,

505 patients were studied in the United States

* Rotigotine was studied at doses of 0.5, 1, 2 and 3 mg/24 hours over a

period of six months, with all doses showing improvement over placebo

* Rotigotine, in doses of 2 and 3 mg/24 hours over a period of six months,

resulted in a statistically significant improvement in IRLS sum score

and a clini
'/>"/>

SOURCE UCB, Inc.
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. TransPharma Medical Announces Positive Results of Phase I Clinical Trials for Transdermal Delivery of hPTH (1-34) for Osteoporosis Treatment
2. NuPathe Reports Positive Phase One Results for NP101 Transdermal Therapy for Acute Migraine
3. Daytrana (methylphenidate transdermal system) Provides Significant Effectiveness in ADHD Symptom Relief in Both Boys and Girls
4. 12-Month Study Demonstrated Tolerability and Efficacy of DAYTRANA (methylphenidate transdermal system)
5. Phosphagenics to Commence Phase 1b Transdermal Insulin Clinical Trial in Second Quarter
6. When Volume Matters, Immunoassay Systems Deliver
7. Genetic Analysis Systems Enter the Clinical Mainstream
8. New Quality Control Systems for Every Laboratory Application
9. Immunoassay Systems - Your Laboratory Workhorse
10. Gene Therapy Eradicates Pancreatic Cancer in Preclinical Trial Targeting Systems Success in Mouse Model Reported in Cancer Cell
11. Researchers Discover Method for Identifying How Cancer Evades the Immune System
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/26/2015)...  Tandem Diabetes Care®, Inc. (NASDAQ: TNDM ... t:slim® and t:flex™ Insulin Pumps, today announced the pricing ... its common stock at a price to the public ... from this offering are expected to be $56.3 million, ... offering expenses payable by Tandem. All of the shares ...
(Date:2/26/2015)... , Feb. 26, 2015  Mail-service and ... consumers, employers and government health plans $23.3 ... released by the Pharmaceutical Care Management Association (PCMA). ... drugs offers one of the easiest ways to ... Mark Merritt . "Policymakers should resist efforts ...
(Date:2/26/2015)... , Feb. 26, 2015  BD Life Sciences, a ... BDX ), a leading global medical ... focused on enabling high-resolution biology, today announced that ... for highly multiplexed cell isolation and single-cell gene ... BD,s powerful BD FACS™ single-cell sorting instrumentation and ...
Breaking Medicine Technology:Tandem Diabetes Care Announces Pricing of Underwritten Public Offering of Common Stock 2Tandem Diabetes Care Announces Pricing of Underwritten Public Offering of Common Stock 3PCMA: Report Shows High-Tech Specialty and Mail-Service Pharmacies Will Reduce Costs for Texas Employers, Consumers and Public Programs by $23.3 Billion 2BD and Cellular Research Announce Co-marketing Efforts for Single-Cell Sequencing 2BD and Cellular Research Announce Co-marketing Efforts for Single-Cell Sequencing 3
... YORK, Dec. 15, 2011  New York University and the ... they have appointed Theodore (Ted) Rappaport, 51, to lead ... Rappaport, currently the William and Bettye ... at Austin (UTA), is a leading educator and entrepreneur ...
... 15, 2011  Today, the Consumer Healthcare Products Association (CHPA), announced ... Five Moms campaign to raise awareness of ... of two teenage boys and a high school math teacher ... the dangers of substance abuse. Millions of ...
Cached Medicine Technology:Wireless Engineering Pioneer Joins NYU-Poly and NYU 2Wireless Engineering Pioneer Joins NYU-Poly and NYU 3Wireless Engineering Pioneer Joins NYU-Poly and NYU 4CHPA's Five Moms Campaign to Stop Medicine Abuse Welcomes New Mom Tammy Walsh 2CHPA's Five Moms Campaign to Stop Medicine Abuse Welcomes New Mom Tammy Walsh 3
(Date:2/27/2015)... 27, 2015 Plugin creators from Pixel Film ... Final Cut Pro X. , “TransFold Volume 3 gives users ... FCPX users.” Said Christina Austin, CEO of Pixel Film ... Cut Pro X editor.” , TransFold Volume 3 comes packed ... The user can decide to change the shadow distance, opacity, ...
(Date:2/26/2015)... (PRWEB) February 27, 2015 2015 Deep ... a professional and in-depth study on the current state ... a focus on the Chinese situation. , Major companies ... SHANGDONG ZOUPING, Hualun, Jiangsu Yuanyang, ZHENGZHOU TONGLI, Hebei ... and Jain & Jain. , The report provides a ...
(Date:2/26/2015)... Yisrayl Hawkins, Pastor and Overseer at The House of Yahweh ... says contains absolute proof that the bible can be trusted ... the plan, or purpose for mankind is. He says a ... beginning and an end. , “Yahweh has allotted 6,000 ... walk in His Righteousness, and who will not. Those who ...
(Date:2/26/2015)... Marking its fifth successful year of business, UV ... the development of a new and improved UV-Aid light supplement ... spring. UV-Aid is a unique and patent pending technology that ... areas of the body susceptible to infection. UVA light has ... daily dose of UV-Aid is equivalent to less than a ...
(Date:2/26/2015)... 2015 Healthpointe is proud to ... Dr. Neil Thomas Katz, MD, is now offering ... throughout Southern California, including Long Beach , ... and fellowship-trained to provide quality care, and specializes ... Neil Katz provides surgical and non-surgical treatments for ...
Breaking Medicine News(10 mins):Health News:Announcing a New TransFold Transition Pack from Pixel Film Studios for Final Cut Pro X Professionals 2Health News:World Benzoyl Peroxide Market Forecast Report 2015-2020 Now at Available DeepResearchReports.com 2Health News:World Benzoyl Peroxide Market Forecast Report 2015-2020 Now at Available DeepResearchReports.com 3Health News:Yisrayl Hawkins Says There is Only One Place Shown in Scripture to Achieve Salvation and Shows Proof in New Letter 2Health News:UV Technologies, LLC Developing New More Effective UV-Aid for Flu and Cold Prevention 2Health News:Southern California Medical Group is Now Offering Orthopedic Care for Cartilage Injuries and Degeneration 2Health News:Southern California Medical Group is Now Offering Orthopedic Care for Cartilage Injuries and Degeneration 3
... found that Salmonella bacteria found in garden birds are ... the bacteria found in livestock and humans. , Salmonella ... undetected in animals, which increases the risk of the ... strains found in birds in the laboratory and found ...
... of NSCLC, CHICAGO, June 2 Exelixis, Inc. ... of XL647, a novel small molecule,inhibitor of EGFR, HER2, ... Society of Clinical Oncology (ASCO). Updated data from an ... cell,lung cancer (NSCLC) patients show encouraging anti-tumor activity of ...
... NEW YORK, June 2 American Oriental,Bioengineering (NYSE: ... of Directors has,authorized a share repurchase program for ... Company,s outstanding common stock., Purchases under this ... in the,open market, privately negotiated transactions, and accelerated ...
... Pain Patients with Substance ... Use Disorders WHO: ... 4th - 6th, ... pm, PHILADELPHIA, June 2 Valley Forge Medical Center and,Hospital is the first facility on ...
... with a combination of chemotherapy, biotherapy and radiotherapy prior ... patients, according to a University of Pittsburgh Cancer Institute ... the American Society of Clinical Oncology (ASCO) in Chicago. ... Cancer Center of the University of Pittsburgh Medical Center ...
... CO June 2, 2008 Results from an ... and lost time among employees suffering from multiple sclerosis ... were presented and announced by Biogen Idec as poster ... annual meeting in Denver, Colorado, May 28-May 31, 2008. ...
Cached Medicine News:Health News:Salmonella in garden birds responsive to antibiotics 2Health News:Exelixis Reports Phase 1 and Phase 2 Data For XL647 at ASCO 2Health News:Exelixis Reports Phase 1 and Phase 2 Data For XL647 at ASCO 3Health News:Exelixis Reports Phase 1 and Phase 2 Data For XL647 at ASCO 4Health News:Exelixis Reports Phase 1 and Phase 2 Data For XL647 at ASCO 5Health News:Exelixis Reports Phase 1 and Phase 2 Data For XL647 at ASCO 6Health News:American Oriental Bioengineering Announces US$75 Million Share Repurchase Program 2Health News:Valley Forge Medical Center and Hospital to Become the First Addiction-Free Pain Management Center of Excellence on the East Coast; Will Host Three Day Professional Training Seminar. 2Health News:Valley Forge Medical Center and Hospital to Become the First Addiction-Free Pain Management Center of Excellence on the East Coast; Will Host Three Day Professional Training Seminar. 3Health News:New treatment combination safe for pancreatic cancer patients 2Health News:New data show patients using avonex reported less sick leave and short-term disability costs 2
... is a standard gelling temperature, high gel ... than 1,000 bp. This Genetic Technology Grade™ ... DNA electrophoresis. DNA recovered from SeaKem GTG ... ligated. SeaKem GTG Agarose is extensively performance ...
... is recommended for separations of DNA fragments ... that are easy to handle, and remains ... minimizes the risk of cracking or breaking. ... (GQT) products with similar sieving properties, is ...
The WADiana Compact is a fully automated immuno-haematology analyser, easy to use with maximum security including clot detection and ensuring no contamination....
... PK7200 works on patented microplate agglutination ... testing system for donor ABO/Rh testing. PK7200 ... syphilis and cytomegalovirus antibody detection. The Automated ... along with the proven reliability that for ...
Medicine Products: